<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>114(6)</volume><submitter>Mansilla A</submitter><pubmed_abstract>The protein complex formed by the Ca&lt;sup>2+&lt;/sup> sensor neuronal calcium sensor 1 (NCS-1) and the guanine exchange factor protein Ric8a coregulates synapse number and probability of neurotransmitter release, emerging as a potential therapeutic target for diseases affecting synapses, such as fragile X syndrome (FXS), the most common heritable autism disorder. Using crystallographic data and the virtual screening of a chemical library, we identified a set of heterocyclic small molecules as potential inhibitors of the NCS-1/Ric8a interaction. The aminophenothiazine FD44 interferes with NCS-1/Ric8a binding, and it restores normal synapse number and associative learning in a Drosophila FXS model. The synaptic effects elicited by FD44 feeding are consistent with the genetic manipulation of NCS-</pubmed_abstract><journal>Proceedings of the National Academy of Sciences of the United States of America</journal><pagination>E999-E1008</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5307446</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Interference of the complex between NCS-1 and Ric8a with phenothiazines regulates synaptic function and is an approach for fragile X syndrome.</pubmed_title><pmcid>PMC5307446</pmcid><pubmed_authors>Sanchez-Barrena MJ</pubmed_authors><pubmed_authors>Campillo NE</pubmed_authors><pubmed_authors>Gonzalez-Rubio JM</pubmed_authors><pubmed_authors>Semelidou O</pubmed_authors><pubmed_authors>Ferrus A</pubmed_authors><pubmed_authors>Infantes L</pubmed_authors><pubmed_authors>Gil C</pubmed_authors><pubmed_authors>Martinez-Gonzalez L</pubmed_authors><pubmed_authors>Mansilla A</pubmed_authors><pubmed_authors>Martinez A</pubmed_authors><pubmed_authors>Skoulakis EM</pubmed_authors><pubmed_authors>Chaves-Sanjuan A</pubmed_authors><pubmed_authors>Conde S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Interference of the complex between NCS-1 and Ric8a with phenothiazines regulates synaptic function and is an approach for fragile X syndrome.</name><description>The protein complex formed by the Ca&lt;sup>2+&lt;/sup> sensor neuronal calcium sensor 1 (NCS-1) and the guanine exchange factor protein Ric8a coregulates synapse number and probability of neurotransmitter release, emerging as a potential therapeutic target for diseases affecting synapses, such as fragile X syndrome (FXS), the most common heritable autism disorder. Using crystallographic data and the virtual screening of a chemical library, we identified a set of heterocyclic small molecules as potential inhibitors of the NCS-1/Ric8a interaction. The aminophenothiazine FD44 interferes with NCS-1/Ric8a binding, and it restores normal synapse number and associative learning in a Drosophila FXS model. The synaptic effects elicited by FD44 feeding are consistent with the genetic manipulation of NCS-</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Feb</publication><modification>2025-04-05T09:35:15.315Z</modification><creation>2019-03-27T02:36:25Z</creation></dates><accession>S-EPMC5307446</accession><cross_references><pubmed>28119500</pubmed><doi>10.1073/pnas.1611089114</doi></cross_references></HashMap>